Riken Vitamin Co., Ltd. (TYO:4526)
Japan · Delayed Price · Currency is JPY 2,913.00
+66.00 (2.32%)
Jun 5, 2026, 3:30 PM JST
Riken Vitamin Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 10,244 | 12,706 | 11,909 | 7,857 | 20,313 |
Depreciation & Amortization | 4,677 | 3,204 | 3,330 | 3,718 | 3,736 |
Loss (Gain) From Sale of Assets | 261 | -34 | 556 | 57 | 61 |
Loss (Gain) From Sale of Investments | -2,563 | -4,054 | -2,090 | -183 | -14,127 |
Other Operating Activities | -2,855 | -2,195 | -1,680 | -337 | -2,002 |
Change in Accounts Receivable | -682 | 1,482 | -2,687 | -1,140 | -947 |
Change in Inventory | -1,943 | -836 | -631 | -2,459 | -1,427 |
Change in Accounts Payable | -285 | -1,982 | 1,383 | 456 | 952 |
Change in Other Net Operating Assets | -891 | -399 | 361 | -134 | 264 |
Operating Cash Flow | 5,963 | 7,892 | 10,451 | 7,835 | 6,823 |
Operating Cash Flow Growth | -24.44% | -24.49% | 33.39% | 14.83% | -10.52% |
Capital Expenditures | -4,863 | -4,678 | -2,536 | -2,112 | -3,250 |
Sale of Property, Plant & Equipment | -149 | 255 | -42 | -38 | -22 |
Cash Acquisitions | 62 | -62 | - | - | - |
Divestitures | - | - | - | - | -445 |
Sale (Purchase) of Intangibles | -133 | -134 | -446 | -15 | -110 |
Investment in Securities | 6,621 | 4,923 | 2,325 | 121 | 617 |
Other Investing Activities | 209 | 49 | 145 | 10 | -451 |
Investing Cash Flow | 1,747 | 353 | -554 | -2,034 | -3,661 |
Short-Term Debt Issued | - | - | 4,100 | - | - |
Long-Term Debt Issued | - | 5,000 | - | - | 18,237 |
Total Debt Issued | - | 5,000 | 4,100 | - | 18,237 |
Short-Term Debt Repaid | -200 | -4,000 | - | -370 | -9,585 |
Long-Term Debt Repaid | -2,573 | -7,138 | -2,606 | -2,606 | -14,289 |
Total Debt Repaid | -2,773 | -11,138 | -2,606 | -2,976 | -23,874 |
Net Debt Issued (Repaid) | -2,773 | -6,138 | 1,494 | -2,976 | -5,637 |
Issuance of Common Stock | - | 93 | - | - | - |
Repurchase of Common Stock | -2,000 | -1,133 | -6,360 | - | - |
Common Dividends Paid | -3,242 | -2,776 | -2,194 | -1,582 | -1,385 |
Other Financing Activities | -25 | -11 | -24 | -20 | -543 |
Financing Cash Flow | -8,040 | -9,965 | -7,084 | -4,578 | -7,565 |
Foreign Exchange Rate Adjustments | 549 | 413 | 672 | 369 | 811 |
Miscellaneous Cash Flow Adjustments | 76 | 1 | - | - | 1 |
Net Cash Flow | 295 | -1,306 | 3,485 | 1,592 | -3,591 |
Free Cash Flow | 1,100 | 3,214 | 7,915 | 5,723 | 3,573 |
Free Cash Flow Growth | -65.77% | -59.39% | 38.30% | 60.17% | -9.04% |
Free Cash Flow Margin | 1.14% | 3.36% | 8.65% | 6.45% | 4.51% |
Free Cash Flow Per Share | 37.24 | 106.15 | 242.66 | 174.45 | 108.93 |
Cash Interest Paid | 115 | 113 | 113 | 127 | 274 |
Cash Income Tax Paid | 2,838 | 2,113 | 1,696 | 327 | 1,909 |
Levered Free Cash Flow | 904.5 | 2,081 | 5,531 | 3,551 | -11,821 |
Unlevered Free Cash Flow | 975.75 | 2,158 | 5,601 | 3,633 | -11,710 |
Change in Working Capital | -3,801 | -1,735 | -1,574 | -3,277 | -1,158 |